Company profile
Home | GSK
At GSK, we unite science, technology and talent to get ahead of disease together
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
CS01 | Transaction MzQzNjg0NDMzNWFkaXF6a2N4
Published 23 Sep 2024 12:37
AD04 | Transaction MzQzNjg0MTA5MGFkaXF6a2N4
Published 23 Sep 2024 12:10
AD03 | Transaction MzQzNjgzMDIxNWFkaXF6a2N4
Published 23 Sep 2024 10:55
CH01 | Transaction MzQzNjY4MTAzNWFkaXF6a2N4
Published 23 Sep 2024 06:05
AD01 | Transaction MzQzNTIyMjQxOWFkaXF6a2N4
Published 11 Sep 2024 02:01
Company registered at Companies House
1 Apr 2022 to 31 Mar 2024
At GSK we seek to protect the natural resources needed to ensure the continued delivery of our high-quality products to patients and consumers in the future. GSK as a company aims to reduce our environmental impact by one quarter by 2030, cutting greenhouse gas emissions, reducing water impact and redirecting waste for beneficial use. Not only is GSK comm...
1 Jun 2021 to 31 May 2023
In order to meet National and International medicines demand, both small and large pharmaceutical companies need to use multiple suppliers. It takes significant effort to coordinate these separate companies and create an integrated plan that safely ensures patients get the medicines they need. Any changes to the plan take time and effort to manage and thi...
1 Feb 2021 to 30 Jun 2024
The threat posed to human life by infectious diseases cannot be underestimated, as the SARS-CoV-2 viral pandemic highlighted. Of the 56 million global deaths a year, 18% are due to infectious diseases. Mortality is not the only burden; the United Nations estimate the cost of the SARS-CoV-2 pandemic will be US$1 trillion. Secondary bacterial infections sig...
